Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Apr 14:373:n716.
doi: 10.1136/bmj.n716.

Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial

Sidsel Boie  1 , Julie Glavind  2 , Niels Uldbjerg  2 , Philip J Steer  3 , Pinar Bor  1 ; CONDISOX trial group
Collaborators, Affiliations
Randomized Controlled Trial

Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial

Sidsel Boie et al. BMJ. .

Erratum in

Abstract

Objective: To determine whether discontinuing oxytocin stimulation in the active phase of induced labour is associated with lower caesarean section rates.

Design: International multicentre, double blind, randomised controlled trial.

Setting: Nine hospitals in Denmark and one in the Netherlands between 8 April 2016 and 30 June 2020.

Participants: 1200 women stimulated with intravenous oxytocin infusion during the latent phase of induced labour.

Intervention: Women were randomly assigned to have their oxytocin stimulation discontinued or continued in the active phase of labour.

Main outcome measure: Delivery by caesarean section.

Results: A total of 607 women were assigned to discontinuation and 593 to continuation of the oxytocin infusion. The rates of caesarean section were 16.6% (n=101) in the discontinued group and 14.2% (n=84) in the continued group (relative risk 1.17, 95% confidence interval 0.90 to 1.53). In 94 parous women with no previous caesarean section, the caesarean section rate was 7.5% (11/147) in the discontinued group and 0.6% (1/155)in the continued group (relative risk 11.6, 1.15 to 88.7). Discontinuation was associated with longer duration of labour (median from randomisation to delivery 282 v 201 min; P<0.001), a reduced risk of hyperstimulation (20/546 (3.7%) v 70/541 (12.9%); P<0.001), and a reduced risk of fetal heart rate abnormalities (153/548 (27.9%) v 219/537 (40.8%); P<0.001) but rates of other adverse maternal and neonatal outcomes were similar between groups.

Conclusions: In a setting where monitoring of the fetal condition and the uterine contractions can be guaranteed, routine discontinuation of oxytocin stimulation may lead to a small increase in caesarean section rate but a significantly reduced risk of uterine hyperstimulation and abnormal fetal heart rate patterns.

Trial registration: ClinicalTrials.gov NCT02553226.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support for the submitted work as detailed above; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Consort flow diagram
None
See this image and copyright information in PMC

References

    1. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2018. Natl Vital Stat Rep 2019;68:1-47. - PubMed
    1. World Health Organization. WHO recommendations: Induction of labour at or beyond term. 2018. https://www.ncbi.nlm.nih.gov/pubmed/30629393. - PubMed
    1. Hedegaard M, Lidegaard Ø, Skovlund CW, Mørch LS, Hedegaard M. Reduction in stillbirths at term after new birth induction paradigm: results of a national intervention. BMJ Open 2014;4:e005785. 10.1136/bmjopen-2014-005785 - DOI - PMC - PubMed
    1. Daly D, Minnie KCS, Blignaut A, et al. . How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries. PLoS One 2020;15:e0227941. 10.1371/journal.pone.0227941 - DOI - PMC - PubMed
    1. Simpson KR, Knox GE. Oxytocin as a high-alert medication: implications for perinatal patient safety. MCN Am J Matern Child Nurs 2009;34:8-15, quiz 16-7. 10.1097/01.NMC.0000343859.62828.ee - DOI - PubMed

Publication types

Associated data